Market Access/ News/ News Joy as sickle cell patients get access to Novartis’ Adakveo after NICE ruling Phil Taylor Adakveo, Haematology, HEOR, market access, NICE, Novartis, rare disease, sickle cell disease 0 Comment People living with sickle cell disease (SCD) in England and Wales will be able to get access to Share X Joy as sickle cell patients get access to Novartis’ Adakveo after NICE ruling https://pharmaphorum.com/news/joy-as-sickle-cell-patients-get-access-to-novartis-adakveo-after-nice-ruling/